Lovastatin plus probucol for prevention of restenosis after percutaneous transluminal coronary angioplasty

The American Journal of Cardiology
J H O'KeefeB D McCallister

Abstract

Combination lovastatin and probucol reduced total cholesterol (27%) and low-density lipoprotein levels (30%), but did not prevent restenosis or clinical events during the first 6 months after percutaneous transluminal coronary angioplasty.

References

Jun 1, 1991·American Heart Journal·R SahniV S Banka
Jan 1, 1995·Mayo Clinic Proceedings·J H O'KeefeB D McCallister
Nov 17, 1994·The New England Journal of Medicine·W S WeintraubS J DeMaio

❮ Previous
Next ❯

Citations

May 31, 2002·International Journal of Cardiology·Marc HorlitzJosef Niebauer
Aug 7, 1997·The New England Journal of Medicine·M N DiazJ F Keaney
Apr 29, 1998·The American Journal of Cardiology·A J LanskyM B Leon
Nov 7, 1998·Current Problems in Cardiology·W H FrishmanM Weiss
Oct 6, 2000·The American Journal of Cardiology·J J PopmaS Kinlay
Mar 21, 2003·The American Journal of Cardiology·Jean-Claude Tardif
Aug 26, 2014·Expert Opinion on Pharmacotherapy·Elena GuerraAdnan Kastrati
Jul 2, 2005·Expert Opinion on Emerging Drugs·J Linde, B H Strauss
Apr 1, 2005·Expert Review of Pharmacoeconomics & Outcomes Research·Paul Scuffham
Oct 16, 2002·Arteriosclerosis, Thrombosis, and Vascular Biology·B Greg BrownAlan Chait
Dec 13, 1997·Circulation·G L NunesB C Berk
Dec 28, 2006·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Cecile TissotYacine Aggoun
Jan 20, 2004·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Jean-Claude TardifPhilippe L L'Allier
Mar 23, 2010·The Psychoanalytic Quarterly·Alessandra Lemma
Apr 29, 1998·Current Opinion in Lipidology·M Fisher, P H Groves
Nov 24, 2005·The Annals of Pharmacotherapy·Amy M Franks, Stephanie F Gardner
Mar 28, 2002·Pharmacology & Therapeutics·S M GarasN A Scott

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.